Showing results (1-10 of 348) with videos related to
Sort By:
Pageof 35
Biochemical Pharmacology|May 8, 1992
Stabilization of the peripheral-type benzodiazepine acceptor by specific phospholipidsP N Moynagh, D C WilliamsJournal of Neurochemistry|February 1, 1994
The peripheral-type benzodiazepine receptor is present in astrocytes but is not a primary site of action for convulsants/anticonvulsantsP N Moynagh, A Schousboe, D C WilliamsJournal of Immunology (Baltimore, Md. : 1950)|September 15, 1994
Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidantsP N Moynagh, D C Williams, L A O'NeillThe Biochemical Journal|September 1, 1993
Interleukin-1 activates transcription factor NF kappa B in glial cellsP N Moynagh, D C Williams, L A O'NeillBiochemical Pharmacology|September 1, 1993
Interleukin-1 and phorbol myristate acetate modulate the peripheral-type benzodiazepine receptor in lymphocytes and glial cellsP N Moynagh, L A O'Neill, D C WilliamsBiochemical Pharmacology|May 17, 1996
Hexachlorocyclohexanes inhibit steroidogenesis in Y1 cells. Absence of correlation with binding to the peripheral-type benzodiazepine binding siteD M Zisterer, P N Moynagh, D C WilliamsThe Biochemical Journal|April 15, 1991
Immunological studies on the rat peripheral-type benzodiazepine acceptorP N Moynagh, C J Bailey, S J Boyce, et al.Life Sciences|January 1, 1995
PK 11195 reduces the brain availability of lindane in rats and the convulsions induced by this neurotoxic agentD M Zisterer, C Suñol, P N Moynagh, et al.The Journal of Endocrinology|November 5, 2003
Toll-like receptor signalling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoidsP N MoynaghJournal of Immunology (Baltimore, Md. : 1950)|August 10, 1999
Antiinflammatory effects of glucocorticoids in brain cells, independent of NF-kappa BE Bourke, P N MoynaghPageof 35